Clinical application of targeted and genome-wide technologies: can we predict treatment responses in chronic lymphocytic leukemia?

Author： Alsolami Reem   Knight Samantha JL   Schuh Anna  

Publisher： Future Medicine

ISSN： 1741-0541

Source： Personalized Medicine, Vol.10, Iss.4, 2013-06, pp. : 361-376

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Ofatumumab for the treatment of chronic lymphocytic leukemia

By Robak Tadeusz  

Therapy, Vol. 6, Iss. 4, 2009-07 ,pp. : 577-587

Future Medicine

Access to resources Recommend Favorite

Clinical Application of Array-Based Comparative Genomic Hybridization for the Identification of Prognostically Important Genetic Alterations in Chronic Lymphocytic Leukemia

By Higgins Russell A.   Gunn Shelly R.   Robetorye Ryan S.  

Molecular Diagnosis & Therapy, Vol. 12, Iss. 5, 2008-01 ,pp. : 271-280

Adis International

Access to resources Recommend Favorite

Intrahepatic interferon‐stimulated gene responses: Can they predict treatment responses in chronic hepatitis C infection?

By  

HEPATOLOGY, Vol. 46, Iss. 5, 2007-11 ,pp. : 1326-1328

John Wiley & Sons Inc

Access to resources Recommend Favorite

Genetic Heterogeneity in Chronic Lymphocytic Leukemia: What Can Conventional Cytogenetics Add?

By  

Acta Haematologica, Vol. 138, Iss. 1, 2017-07 ,pp. : 31-32

Karger

Access to resources Recommend Favorite

New oral small molecules in the treatment of chronic lymphocytic leukemia

By  

CANCER, Vol. 121, Iss. 12, 2015-06 ,pp. : 1917-1926

John Wiley & Sons Inc

Access to resources Recommend Favorite